Zotarolimus (ABT-578) is a derivative of Rapamycin (HY-10219), with anti-proliferative activity. Zotarolimus is an immunosuppressant. Zotarolimus is developed specifically for local delivery from stents for the prevention of coronary artery restenosis[1][2].
Molecular Weight:
966.21
Purity:
98.59
CAS Number:
[221877-54-9]
Formula:
C52H79N5O12
Target:
Drug Derivative
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted